• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羊膜腔内注入表面活性剂预防新生儿呼吸窘迫综合征(IRDS):理论依据与个人经验

Intraamniotic surfactant for prevention of neonatal respiratory distress syndrome (IRDS): rationale and personal experience.

作者信息

Cosmi E V, La Torre R, Piazze J J, Maranghi G L, Lerro N, Bianco D, Anceschi M M

机构信息

2nd Department of Obstetrics and Gynecology, University La Sapienza, Policlinico Umberto I, Rome, Italy.

出版信息

Eur J Obstet Gynecol Reprod Biol. 1997 Feb;71(2):135-9. doi: 10.1016/s0301-2115(96)02623-1.

DOI:10.1016/s0301-2115(96)02623-1
PMID:9138955
Abstract

OBJECTIVE

To evaluate the efficacy of intramniotic instillation of supplementary surfactant for the prophylaxis of neonatal IRDS in an emergency obstetric setting.

STUDY DESIGN

Supplementary natural surfactant (SS) was administered intra-amniotically (80 mg in 1 ml) under ultrasound guidance in the proximity of the fetal nostrils and mouth in six pregnant women at 24-32 weeks gestation, with immature amniotic fluid indices of fetal lung maturity, and whose delivery was imminent because of severe fetal distress, deteriorating maternal conditions, or refractory vaginal bleeding. The administration of SS was preceded by IV aminophylline to the mother (a bolus of 240 mg over 10 min, and a maintenance dose of 0.02-0.1 mg kg-1 min-1) in order to elicit sustained fetal breathing movements.

RESULTS

The clinical conditions of the six newborn infants were good with no respiratory problems in four cases, and with mild IRDS in the remaining two, which, however, resolved uneventfully.

CONCLUSIONS

It is suggested that this prophylactic approach has a great potential for becoming a reliable option for the antenatal prevention of IRDS.

摘要

目的

评估在紧急产科情况下羊膜腔内注入补充表面活性剂预防新生儿呼吸窘迫综合征(IRDS)的疗效。

研究设计

对6例妊娠24 - 32周、羊水胎儿肺成熟指标不成熟、因严重胎儿窘迫、母体情况恶化或难治性阴道出血而即将分娩的孕妇,在超声引导下于胎儿鼻孔和嘴附近羊膜腔内注入补充天然表面活性剂(SS,1毫升含80毫克)。在注入SS之前,先给母亲静脉注射氨茶碱(10分钟内推注240毫克,维持剂量为0.02 - 0.1毫克/千克/分钟),以引发胎儿持续呼吸运动。

结果

6例新生儿临床状况良好,4例无呼吸问题,其余2例有轻度IRDS,但均顺利康复。

结论

提示这种预防方法很有可能成为产前预防IRDS的可靠选择。

相似文献

1
Intraamniotic surfactant for prevention of neonatal respiratory distress syndrome (IRDS): rationale and personal experience.羊膜腔内注入表面活性剂预防新生儿呼吸窘迫综合征(IRDS):理论依据与个人经验
Eur J Obstet Gynecol Reprod Biol. 1997 Feb;71(2):135-9. doi: 10.1016/s0301-2115(96)02623-1.
2
Surfactant administration to the human fetus in utero: a new approach to prevention of neonatal respiratory distress syndrome (RDS).宫内给人类胎儿使用表面活性剂:预防新生儿呼吸窘迫综合征(RDS)的新方法。
J Perinat Med. 1996;24(2):191-3. doi: 10.1515/jpme.1996.24.2.191.
3
[Intraamniotic surfactant supply as RDS prevention].[羊膜腔内注入表面活性剂预防呼吸窘迫综合征]
Med Wieku Rozwoj. 2003 Jul-Sep;7(3 Suppl 1):255-60.
4
Antenatal modes of surfactant administration for RDS prevention: a review.预防呼吸窘迫综合征的产前表面活性剂给药方式:综述
J Natl Med Assoc. 2006 Mar;98(3):340-4.
5
Impact of antenatal dexamethasone administration on respiratory distress syndrome in surfactant-treated infants.产前给予地塞米松对接受表面活性剂治疗的婴儿呼吸窘迫综合征的影响。
Am J Obstet Gynecol. 1989 Sep;161(3):628-33. doi: 10.1016/0002-9378(89)90367-0.
6
Prophylaxis of neonatal respiratory distress syndrome by intra-amniotic administration of pulmonary surfactant.通过羊膜腔内注入肺表面活性物质预防新生儿呼吸窘迫综合征
Chin Med J (Engl). 2004 Jan;117(1):120-4.
7
Antenatal use of ambroxol for the prevention of infant respiratory distress syndrome.氨溴索产前应用预防婴儿呼吸窘迫综合征。
J Obstet Gynaecol Res. 2000 Aug;26(4):307-12. doi: 10.1111/j.1447-0756.2000.tb01327.x.
8
Comparison of two strategies for surfactant prophylaxis in very premature infants: a multicenter randomized trial.极早产儿两种表面活性剂预防策略的比较:一项多中心随机试验
Pediatrics. 1998 Jun;101(6):1006-12. doi: 10.1542/peds.101.6.1006.
9
[Prevention of neonatal respiratory distress syndrome through the administration of prednisolone in the fetal period].
Zentralbl Gynakol. 1976;98(13):769-73.
10
Requirements of perinatal prevention and treatment of respiratory distress syndrome.围产期呼吸窘迫综合征的防治要求。
Eur Respir J Suppl. 1989 Mar;3:68s-72s.

引用本文的文献

1
Surfactant therapy: the current practice and the future trends.表面活性剂疗法:当前实践与未来趋势。
Sudan J Paediatr. 2013;13(1):11-22.
2
The role of surfactant in respiratory distress syndrome.表面活性剂在呼吸窘迫综合征中的作用。
Open Respir Med J. 2012;6:44-53. doi: 10.2174/1874306401206010044. Epub 2012 Jul 13.
3
Intra-amniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newborns.羊膜腔内注入表面活性剂用于有早产风险的妇女以预防新生儿呼吸窘迫。
Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD007916. doi: 10.1002/14651858.CD007916.pub2.
4
Antenatal modes of surfactant administration for RDS prevention: a review.预防呼吸窘迫综合征的产前表面活性剂给药方式:综述
J Natl Med Assoc. 2006 Mar;98(3):340-4.